Ensysce Biosciences (ENSC) Stock Price, Quote, News & History

Q: What sector and industry does Ensysce Biosciences (ENSC) operate in?

Ensysce Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Ensysce Biosciences (ENSC) Stock Price, Quote, News & History

ENSCNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$0.7213

-0.067-8.50%

Last update: Jan 29, 10:40 AM

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$0.77

Volume / Avg.

77.39K / 203.03K

Day Range

$0.70 - $0.77

52 Wk Range

0.76 - 7.65

Market Cap

$2.55M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

4.75%

Days to Cover

1.25

Recent Ensysce Biosciences Inc News

Why ServiceNow Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Ensysce Biosciences Stock Doubles In One Trading Session - Here's Why

Ensysce Biosciences rises after patent notice for PF9001, a methadone prodrug aimed at safer opioid use with overdose protection technology.

Vandana Singh

Crude Oil Falls Over 3%; Philip Morris Earnings Top Views

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-7.04M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

4.69M

Free Cash Flow (TTM)

-7.17M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-2.48M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.55M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

2.35

Earnings Yield % (TTM)

-814.10%

Earnings Yield % (FWD)

-37.18%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.33

Company Debt

Total Debt

$387.70K

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$1.67M

Debt to Equity

0.32

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$0.77

Volume / Avg.

77.39K / 203.03K

Day Range

$0.70 - $0.77

52 Wk Range

0.76 - 7.65

Market Cap

$2.55M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

4.75%

Days to Cover

1.25

About

Sector

Health Care

Industry

Biotechnology

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overd...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Ensysce Biosciences (ENSC) stock?

You can purchase shares of Ensysce Biosciences (NASDAQ:ENSC) through any online brokerage.

View our list of the best stock brokerages

Who are Ensysce Biosciences (ENSC) competitors?

Other companies in Ensysce Biosciences’s space includes: Bio Green Med Solution Inc (NASDAQ:BGMSP), AquaBounty Technologies Inc (NASDAQ:AQB), Medicus Pharma Ltd (NASDAQ:MDCXW), Biodexa Pharmaceuticals PLC (NASDAQ:BDRX) and Cardio Diagnostics Holdings Inc (NASDAQ:CDIO).

What is the forecast, or price target, for Ensysce Biosciences (ENSC) stock?

Ensysce Biosciences has a consensus price target of $7.00.

What is the current price for Ensysce Biosciences (ENSC)?

The stock price for Ensysce Biosciences (NASDAQ: ENSC) is $0.7213 last updated January 29, 2026 at 10:40 AM EST.

Does Ensysce Biosciences (ENSC) pay a dividend?

There are no upcoming dividends for Ensysce Biosciences.

When is Ensysce Biosciences (NASDAQ:ENSC) reporting earnings?

Ensysce Biosciences does not have any upcoming earnings scheduled.

Is Ensysce Biosciences (ENSC) going to split?

There is no upcoming split for Ensysce Biosciences.

What sector and industry does Ensysce Biosciences (ENSC) operate in?

Ensysce Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Bio Green Med Solution Inc

NASDAQ:BGMSP

$3.70

No data available

AquaBounty Technologies Inc

Biodexa Pharmaceuticals PLC

NASDAQ:BDRX

$1.87

-10.09%

Cardio Diagnostics Holdings Inc

NASDAQ:CDIO

$1.63

-8.42%

Psyence Biomedical Ltd

Silexion Therapeutics Corp

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$0.77

Volume / Avg.

77.39K / 203.03K

Day Range

$0.70 - $0.77

52 Wk Range

0.76 - 7.65

Market Cap

$2.55M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

4.75%

Days to Cover

1.25

Recent Ensysce Biosciences Inc News

Why ServiceNow Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Ensysce Biosciences Stock Doubles In One Trading Session - Here's Why

Ensysce Biosciences rises after patent notice for PF9001, a methadone prodrug aimed at safer opioid use with overdose protection technology.

Vandana Singh

Crude Oil Falls Over 3%; Philip Morris Earnings Top Views

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-7.04M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

4.69M

Free Cash Flow (TTM)

-7.17M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-2.48M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.55M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

2.35

Earnings Yield % (TTM)

-814.10%

Earnings Yield % (FWD)

-37.18%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.33

Company Debt

Total Debt

$387.70K

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$1.67M

Debt to Equity

0.32

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$0.77

Volume / Avg.

77.39K / 203.03K

Day Range

$0.70 - $0.77

52 Wk Range

0.76 - 7.65

Market Cap

$2.55M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

4.75%

Days to Cover

1.25

About

Sector

Health Care

Industry

Biotechnology

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry